AT
Adhera Therapeutics Inc
ATRX · OTC
$0.00 +0.00% (+$0.00)
Market Cap $722.0
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
57 /100
Average ROIC 61.78%
ROA 2,675.95%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -0.51x
Debt/Equity N/A
Stability
10 /100
Unstable Beta 873.86x
EPS volatility 63.42%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ATRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Battat
Employees
2
Headquarters
Baton Rouge